Drupal.behaviors.print = function(context) {window.print();window.close();}>
Baylor, Georgia Tech Teams Collaborating on Protein, Metabolite Markers for Ovarian Cancer
January 20, 2012
Baylor, Georgia Tech Teams Collaborating on Protein, Metabolite Markers for Ovarian Cancer
Full-text access for premium subscribers only.
Existing premium subscribers
login here
.
New to GenomeWeb?
Register here
quickly.
Related Stories
Georgia Tech Team Claims 100 Percent Accuracy for Metabolomic Ovarian Cancer Test in Initial Trial
August 20, 2010 / ProteoMonitor
Vermillion Posts 8 Percent Increase in OVA1 Sales, Announces Shift in Commercialization Strategy
May 17, 2013 / ProteoMonitor
Vermillion's OVA1 Sales Increase 8 Percent in Q1
May 16, 2013 / GenomeWeb Daily News
GenomeWeb Feature: The Unsteady March of Cancer Protein Biomarkers into the Clinic
May 10, 2013 / ProteoMonitor
Vermillion Inks CRADA with Army to Evaluate OVA1
April 17, 2013 / GenomeWeb Daily News